9-Nitrocamptothecin inhibits HIV-1 repli
โ
Chia-Ling Hung; Jay Doniger; Alessio Palini; Stuart W. Snyder; Michael F. Radono
๐
Article
๐
2001
๐
John Wiley and Sons
๐
English
โ 141 KB
## Abstract The ability of the antiโcancer drug, 9โNitrocamptothecin (9NC), to inhibit replication of HIVโ1 in clinically relevant primary lymphocytic cells was studied. Primary peripheral blood lymphocytes (PBLs) from a nonโinfected donor were freshly infected with HIVโ1 and treated with 9NC by us